<DOC>
	<DOCNO>NCT01793701</DOCNO>
	<brief_summary>This first study assess clinical feasibility dose escalation simultaneous integrate boost intensity-modulated radiotherapy patient locally advanced cervical cancer . Following screen confirm eligibility patient commence six week treatment period . After , patient follow visit clinic every 3 month period 24 month ( 2 year ) . End study define 24 month treatment . Patients follow minimum 5 year ( per local policy ) treatment .</brief_summary>
	<brief_title>Intensity-modulated Radiotherapy Locally Advanced Cervical Cancer</brief_title>
	<detailed_description>1 . Primary objective - To determine feasibility dose escalation simultaneous boost intensity-modulated radiotherapy ( IMRT ) locally advanced cervical cancer 2 . Secondary Objectives - To assess objective response rate - To assess local control - To correlate toxicity dose-volume histogram data 3 . Primary endpoint - Grade 3 gastrointestinal toxicity 6 month define CTCAE v3.0 ( Common Terminology Adverse Events ) 4 . Secondary endpoint - Response rate assess radiologically 3 month 12 month - Local control 2 year - Late toxicity 2 year define CTCAE v3.0</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Histologically confirm squamous cell carcinoma , adenocarcinoma poorly differentiate carcinoma cervix 2 . FIGO stage IIBIVA ( pelvic nodal status ) FIGO stage 1B2 IIA pelvic nodal involvement 3 . Measurable disease MRI 4 . Age &gt; 18 year ( upper limit ) 5. WHO performance status 0,1 6 . Adequate renal function EDTA clearance &gt; 55ml/min 7 . Adequate liver function , define ALT AST le 2.5 x ULN , bilirubin le 1.25 x ULN 8 . Adequate bone marrow function , define WCC &gt; 3.0 x 109/litre , neutrophil &gt; 1.5 x 109/litre platelet &gt; 100 x 109 /litre 9 . Able understand give write informed consent 1 . Evidence common iliac paraaortic nodal involvement , distant metastases 2 . Previous history cancer except skin tumour 3 . Previous pelvic radiotherapy surgery toparoscopic node disection 4 . Previous history pelvic adhesion , inflammatory bowel disease , pelvic inflammatory disease diabetes mellitus 5 . Females childbearing potential must negative pregnancy test within 7 day prior register protocol therapy require . Acceptable contraception use barrier hormonal method . 6 . Females must pregnant breastfeed Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Cervical Cancer , Intensity-modulated radiotherapy</keyword>
</DOC>